Discovery of highly potent and efficacious MC4R agonists with spiroindane N-Me-1,2,4-triazole privileged structures for the treatment of obesity.

Source:http://linkedlifedata.com/resource/pubmed/id/20933410

Bioorg. Med. Chem. Lett. 2010 Nov 15 20 22 6524-32

Download in:

View as

General Info

PMID
20933410